Kim Kelderman Power - 17 Aug 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2026, 16:48:33 UTC
Prior SEC filing
18 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.

Key filing fact

Kim Kelderman Power filed Form 4 for BIO-TECHNE Corp (TECH) on 19 Aug 2026.

Key facts

  • This page summarizes Kim Kelderman Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 2 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2026, 16:48.

Change

  • Previous filing in this sequence was filed on 18 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001739054 Primary reporting owner

Kelderman Kim

Relationship
Chief Executive Officer, Director
Address
614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
82,762
Date
17 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+57,590
Change %
Price
$0.000000*
Shares after
57,590
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
57,590
Exercise price
Footnotes
F7, F12
TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+93,582
Change %
Price
$0.000000*
Shares after
93,582
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
93,582
Exercise price
Footnotes
F7, F13
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
115,724
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
115,724
Exercise price
$66.97
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,944
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,944
Exercise price
$120.46
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,940
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
28,940
Exercise price
$94.52
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,492
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,492
Exercise price
$84.61
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,391
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,391
Exercise price
$84.61
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,252
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
38,252
Exercise price
$52.83
Footnotes
F3
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,621
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,621
Exercise price
$68.54
Footnotes
F1
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
51,890
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
51,890
Exercise price
$68.54
Footnotes
F4
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
69,061
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
69,061
Exercise price
$74.91
Footnotes
F5
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
90,441
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
90,441
Exercise price
$53.60
Footnotes
F6
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
51,261
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
51,261
Exercise price
Footnotes
F7, F8
TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
70,708
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
70,708
Exercise price
Footnotes
F7, F9
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,544
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,544
Exercise price
Footnotes
F7, F10
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,569
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,569
Exercise price
Footnotes
F7, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Fully exercisable.

Footnote F2

Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.

Footnote F3

Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.

Footnote F4

Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

Footnote F5

Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.

Footnote F6

Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

Footnote F7

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F8

Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F9

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F10

8,544 restricted stock units vest on 8/15/2027.

Footnote F11

11,785 restricted stock units vest on 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.

Footnote F12

19,197 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 19,196 restricted stock units vest on 8/17/2029.

Footnote F13

93,582 restricted stock units vest on 8/17/2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .